The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Схожие документы

• Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
  по: Peterson, Danielle, et al.
  Опубликовано: (2020)
• When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection
  по: Damsky, William, et al.
  Опубликовано: (2020)
• Sexual transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A new possible route of infection?
  по: Patrì, Angela, et al.
  Опубликовано: (2020)
• Potential inhibitors for the novel coronavirus (SARS-CoV-2)
  по: Han, Yanqiang, et al.
  Опубликовано: (2020)
• Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2
  по: Rajasekharan, Sreejith, et al.
  Опубликовано: (2021)